Petrikor Pharma Pvt Ltd
A next-generation pharmaceutical company headquartered in Kolkata, West Bengal — founded by technocrats and doctors, built on scientific excellence, clinical expertise, and an unwavering commitment to improving human health. Backed by UAE strategic investment and a robust contract manufacturing network.
Who We Are
Petrikor Pharma Pvt. Ltd. is a dynamic and innovative pharmaceutical company based in Kolkata, India. Founded by a dedicated group of technocrats and doctors with extensive experience, our company is built on a foundation of scientific excellence, clinical expertise, and an unwavering commitment to improving human health.
From day one, we have moved with purpose. Within our first year, we have established contract manufacturing agreements with three WHO-GMP compliant manufacturers, secured supply contracts across multiple therapeutic categories, and attracted a 40% strategic stake from a UAE-based investment partner — validating both our commercial model and our long-term vision.
Our current focus is branded generics — high-quality, affordable versions of established medicines, delivered under our own brand and supported by a professional sales and medical affairs team. As we grow, our portfolio will expand into injectables, nutraceuticals, intensive healthcare, medical devices, and disposables.
“Quality is the cornerstone of everything we do — from the sourcing of raw materials to the final packaging of our products.”
— Founding Philosophy, Petrikor PharmaIncorporated in India in 2025, operating under all applicable regulatory frameworks including the Drugs & Cosmetics Act, CDSCO guidelines, and Schedule M compliance standards.
Our founding team brings together accomplished technocrats with deep manufacturing expertise alongside seasoned medical doctors who ensure every product is clinically relevant and patient-focused.
We work with established contract manufacturers and supply partners to ensure consistent quality, uninterrupted supply, and WHO-GMP compliant production across all product categories.
A 40% strategic stake from a UAE-based investment partner underscores our credibility, commercial potential, and readiness to expand distribution across the Middle East and beyond.
The name “Petrikor” (Petrichor) evokes the distinct, earthy scent that often accompanies the first rain after a long period of dry weather. We chose this name because it symbolises new beginnings, renewal, and the promise of life — a perfect metaphor for our mission to bring fresh, life-enhancing pharmaceutical solutions to the market.
Our Difference
In a crowded market, we know that trust is earned. Here is what sets Petrikor Pharma apart.
We are not just businesspeople in the pharmaceutical industry — we are professionals who have lived and breathed it. Our unique blend of technical expertise from our technocrat founders and clinical insight from our medical doctor founders ensures that our products are meticulously crafted from the ground up, with patient safety and efficacy at the forefront of every decision.
Our partner's state-of-the-art manufacturing facility is a testament to our commitment to excellence. We adhere to the most rigorous national and international quality standards — from sourcing the purest raw materials to implementing advanced quality control protocols. When you choose Petrikor Pharma, you are choosing a product that has been subject to uncompromising scrutiny.
As a new company, we have the agility and freedom to focus on real-world medical needs. We are dedicated to identifying gaps in the market and developing solutions that are not only effective but also affordable and accessible. Our innovation is not just about new drugs — it's about providing better value and better outcomes for patients.
We are proud to be a part of Kolkata's rich pharmaceutical history. Our strategic location provides a strong foundation for both our domestic and international distribution networks — ensuring a steady supply chain and timely delivery, so our products can reach those who need them most, efficiently and reliably.
We believe in building strong, collaborative relationships with healthcare professionals, pharmacists, and distributors. Our mission is to be more than just a supplier — we aim to be a trusted partner in the healthcare ecosystem, working together to improve the quality of life for communities both in India and around the globe.
Our Team
Petrikor Pharma is led by a unique blend of industry veterans. Our leadership team includes accomplished technocrats with a deep understanding of pharmaceutical manufacturing and process optimisation, alongside seasoned medical doctors who bring invaluable clinical insights.
This powerful combination ensures that every product we develop is not only scientifically sound but also clinically relevant and patient-focused. We are united by a shared passion for making a positive difference in the world.
Deep expertise in pharmaceutical manufacturing, process optimisation, supply chain management, and operational excellence — driving efficiency and quality at every step.
Invaluable clinical insights that ensure every product addresses real patient needs. Our doctors bring front-line healthcare understanding to every product development decision.
Our diverse backgrounds allow us to approach challenges from multiple perspectives, leading to more robust, effective, and commercially viable solutions — faster.
Stringent quality control measures at every step — from raw material sourcing to final packaging.
Partner facilities equipped with the latest technology to ensure products are safe, effective, and consistent.
Adherence to rigorous national and international standards including WHO-GMP and revised Schedule M.
Building a legacy of trust and reliability with our partners, healthcare professionals, and the patients we serve.
Continuous investment in research, development, and innovation to address unmet medical needs.
When we started Petrikor Pharma, our vision was to create a pharmaceutical company that was different. One that did not just follow convention but led with innovation. As a technocrat, I believe that technology is the ultimate enabler, and when applied with purpose and empathy, it can revolutionise healthcare.
In an industry often seen as traditional, we are introducing a new kind of DNA. Our foundation is built on precision, data-driven decisions, and a commitment to operational excellence. We are leveraging the latest advancements in technology to streamline our processes, enhance our research capabilities, and ensure that every single product we manufacture is of uncompromising quality. We believe that the future of medicine is not just in the molecules we create, but in the intelligent systems and efficient processes that deliver them to you.
Our name, Petrikor, speaks to a powerful idea: the refreshing scent of earth after the first rain. It symbolises renewal, hope, and the promise of new life. This is the promise we make to you. We are dedicated to harnessing our collective expertise to bring fresh, life-enhancing solutions to the world.
We stand at the intersection of technology and humanity. Our team of doctors brings invaluable clinical insight, ensuring that our technological innovations are always directed toward solving real-world medical challenges. This powerful synergy is our greatest asset. Our journey has just begun, and the road ahead is full of incredible possibilities. I invite you to join us on this exciting journey as we work toward our vision — to build a world where high-quality, life-saving medicine is not a privilege, but a universal reality.
Strategic Partnership
Our Network
A carefully curated network of WHO-GMP compliant manufacturers and supply partners, built for quality, scale, and long-term reliability.
Branded generics manufacturing — oral solids & semi-solids
Branded generics — multi-category WHO-GMP facility
Comprehensive branded generics portfolio manufacturing
Injectables, nutraceuticals & intensive healthcare supply
Specialised pharmaceutical supply contracts
Our Portfolio
An extensive portfolio covering the entire therapeutic spectrum — ready for supply launch from June 2026 across India and target international markets.
Our core business — high-quality, affordable branded generic medicines delivered under the Petrikor name, backed by a professional medical sales team.
Core FocusSterile injectable formulations manufactured in WHO-GMP compliant facilities, targeted at hospitals, nursing homes, and intensive care settings.
Supply ReadyA curated range of nutraceutical products addressing nutritional gaps across therapeutic categories, formulated for efficacy and patient compliance.
Supply ReadyCritical care and intensive healthcare products for hospital and institutional use — positioned for both domestic supply and export to GCC markets.
Supply ReadyPlanned foray into syringes, disposables, and medical devices — extending Petrikor's presence across the full continuum of patient care.
PlannedCo-option of senior doctors, pharmacologists, and corporate healthcare institutions planned — building a direct institutional sales channel.
PlannedOur Direction
Petrikor's vision is to become a leading pharmaceutical company — not just in India, but across the markets we serve. Our roadmap is clear, our partnerships are in place, and our team is being built to execute at scale.
Build a recognised, trusted brand across India's therapeutic landscape with a focus on quality, compliance, and doctor relationships.
Leverage UAE partnership to expand into GCC markets, Africa, and Southeast Asia — supported by Pharmexcil RCMC and international regulatory registrations.
Extend beyond pharmaceuticals into medical devices, disposables, and institutional healthcare — becoming a comprehensive healthcare solutions company.
Build a team of passionate, experienced professionals who grow with the company — rewarded by merit, empowered by responsibility.
Join Our Team
We are looking for experienced pharmaceutical professionals who want to be part of a company from its earliest days — shaping strategy, owning functions, and growing with us.
Own Petrikor's entire regulatory function — from CDSCO product registrations and SUGAM portal submissions to eCTD dossiers, pharmacovigilance, Schedule M compliance, and future international regulatory filings. A foundational role that will define our compliance framework.
Manage and develop Petrikor's contract manufacturing network (Astonia, Edwina, Acums) and sourcing operations — overseeing CMO audits, API and excipient procurement, quality agreements, technology transfers, and supply chain readiness for our June 2026 commercial launch.
Lead Petrikor's commercial operations — building our PAN-India field sales force, establishing distribution channels (stockists, C&F, hospital chains, pharmacy networks), managing key accounts, and preparing the company's distribution infrastructure for international expansion into GCC and beyond.
Investor Relations
Petrikor Pharma is backed by a UAE-based strategic investor holding a 40% equity stake — a partnership that validates our commercial model, accelerates our international ambitions, and positions us strongly for the next phase of growth.
In March 2026, Petrikor Pharma Pvt Ltd entered into a landmark equity partnership with a UAE-based strategic investor, who acquired a 40% stake in the company. This is not a passive financial investment — it is a strategic alliance that opens direct pathways into the GCC pharmaceutical market, the Middle East healthcare sector, and broader international distribution networks.
The partnership reflects confidence in Petrikor's business model, the quality of our manufacturing network, and the strength of our founding team. It provides us with the capital, commercial relationships, and international credibility to execute our vision of becoming a leading pharmaceutical company.
The UAE partnership provides strategic entry points into the Gulf Cooperation Council pharmaceutical market — one of the fastest-growing regions for pharmaceutical imports from India.
The 40% equity stake represents meaningful, committed capital that supports our product launch, team building, regulatory investments, and commercial scale-up planned for 2026.
Beyond capital, the partnership creates distribution synergies across healthcare institutions, hospital networks, and pharmaceutical importers in the UAE and wider Middle East region.
Under the India-UAE CEPA (Comprehensive Economic Partnership Agreement), Indian pharmaceutical exports enjoy preferential access to the UAE market — a direct commercial advantage for Petrikor.
We welcome enquiries from institutional partners, distributors, healthcare organisations, and strategic investors who share our vision of delivering quality pharmaceutical products across India and international markets.
Submit an Enquiry →Disclosure Note: The identity of Petrikor's UAE-based strategic investor is not disclosed publicly at this stage in accordance with the terms of the partnership agreement. Verified institutional enquiries may be directed to admin@petrikorpharma.com for further discussion under appropriate confidentiality arrangements.
Latest Updates
Stay updated on Petrikor's commercial milestones, partnerships, regulatory progress, and upcoming launches.
Petrikor Pharma Pvt Ltd is pleased to announce the successful signing of a 40% equity stake acquisition by a UAE-based strategic investor. This landmark partnership marks a defining milestone in the company's journey — providing capital backing, GCC market access, and international commercial distribution synergies. The agreement was signed in March 2026, aligning with Petrikor's preparations for a full commercial product launch in June 2026.
Read More About Our Partnership →Petrikor has successfully executed contract manufacturing agreements with Astonia Pharma, Edwina Labs, and Acums Pharma — three established pharmaceutical manufacturers — covering the company's branded generics portfolio and ensuring WHO-GMP compliant production capacity ahead of the June 2026 launch.
View Our Manufacturing Network →Petrikor has formalised supply contracts with Lunix Pharma and Endocrine Pharma, covering injectables, nutraceuticals, and intensive healthcare product categories. These agreements complete the supply chain foundation required for Petrikor's multi-category product launch scheduled for June 2026.
View Supply Partners →As part of its pre-launch preparation, Petrikor Pharma has opened recruitment for three senior roles — Regulatory Compliance Pharmacist, Manager – Contract Manufacturing & Sourcing, and Head of Sales & Distribution. These foundational hires will shape the company's regulatory, operational, and commercial strategy.
View Open Positions →Get In Touch